Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a computer game fix 'Spatial Neglect' after stroke?

NCT ID NCT07519317

Not yet recruiting Symptom relief Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a home-based eye movement therapy (optokinetic stimulation) for people with spatial neglect after a stroke. Spatial neglect makes it hard to pay attention to one side of the world, often leading to falls. The therapy involves watching moving dots on a computer screen to train the eyes to scan the neglected side. The trial will enroll 90 adults over 60 who had a stroke more than 6 months ago, and will measure improvements in mobility and daily function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
optokinetic stimulation (visual scanning therapy on a computer)
What this could lead to
If it works, this could provide an effective home-based treatment for spatial neglect after stroke, improving mobility and reducing fall risk.
What could go wrong
This is an early-stage trial with only 90 participants, and previous evidence for such treatments is mixed. The therapy may not work for everyone or may be difficult to use at home.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPATIAL NEGLECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

perceptual disorders stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPATIAL NEGLECT

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.